Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Rescuers again fail to free whale stranded on Germany's Baltic coast - 2Israeli media reports Iran attacking greater Tel Aviv region
- 3Winter virus season so far is not too bad, but doctors worry about suffering to come
- 4Why most Jewish Israelis back the death penalty for terrorists
- 5The Solution to Individual budget: Dominating Cash The board
- Moscow: Russia well-positioned to withstand oil market shocks
- Human evolution’s biggest mystery has started to unravel. How 2025 tipped the scales
- Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy
- Instructions to Explore the Therapy Choices for Cellular breakdown in the lungs
- Whale stranded off Germany for days found stuck again
- Investigate These Retreats Well known With Seniors
- Recent studies prove the ancient practice of nasal irrigation is effective at fighting the common cold
- Car Investigation: A Survey of \Past the Outside\ Car
- Instructions to Decide the Best SUV Size for Seniors
